文献速递淋巴瘤造血干细胞移植与细胞治疗

非性腺毒性治疗或可改善男性霍奇金淋巴瘤患者受损的生育力

In male Hodgkin lymphoma patients, impaired fertility may be improved by non-gonadotoxic therapy.
PubMed 文献 · Br J Haematol · 2021-08-31

该研究分析了46例2008至2016年间可获取精液检查的男性霍奇金淋巴瘤患者,探讨疾病及其治疗对精子生成状态的影响。结果显示,III-IV期患者精子数量减少,III-IV期及有B症状者活力和存活率降低,ESR升高和低白蛋白者异常形态增加;造血干细胞移植与精子活力严重受损相关,而未接受移植者生育力在活力方面有统计学显著改善。

要点

  • III-IV期霍奇金淋巴瘤患者诊断时精子数量减少。
  • 有B症状者精子活力和存活率降低。
  • 造血干细胞移植与精子活力严重受损相关。

核心结论

  • 造血干细胞移植导致多数男性霍奇金淋巴瘤患者不育,但一线治疗可改善疾病所致的生育力受损。

研究设计与样本

  • 回顾性分析46例2008至2016年间治疗且精液检查可用的男性霍奇金淋巴瘤患者。

主要发现

  • III-IV期患者精子数量减少;III-IV期及有B症状者活力和存活率降低;ESR升高和低白蛋白者异常形态增加。
  • 造血干细胞移植与精子活力严重受损相关。
  • 未接受造血干细胞移植的霍奇金淋巴瘤治疗患者精子活力有统计学显著改善。

临床怎么用

  • 对男性霍奇金淋巴瘤患者应关注生育力评估,尤其在III-IV期、有B症状、ESR升高或低白蛋白时。
  • 造血干细胞移植前需充分告知不育风险。
  • 非性腺毒性一线治疗可能改善疾病所致的生育力受损。

局限性

  • 样本量较小(46例),需更大系列研究进一步探讨诊断时和治疗后生育力受损的危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The outcome of patients with Hodgkin lymphoma (HL) has improved significantly in recent years, and now attention is increasingly being focused on the well-being of these young patients. This study aimed to analyse the influence of HL and its treatment on the spermatogenic status of 46 male HL patients with available spermiograms, treated between 2008 and 2016. Analysing prognostic factors at diagnosis, we found that the number of spermatozoa was reduced in stage III-IV; motility and vitality were reduced in stage III-IV and in the presence of B symptoms; and abnormal forms were increased in patients with elevated erythrocyte sedimentation rate (ESR) and low albumin. Furthermore, we found that haematopoietic stem cell transplantation (HSCT) was associated with a severe impairment of fertility in terms of sperm motility. In HL-treated patients who did not undergo HSCT we found a statistically significantly improved fertility in terms of motility. In this study, we found that HSCT induced infertility in the majority of male patients with HL, but that first-line treatment could improve the impaired fertility status caused by disease. Further studies are needed in larger case series to investigate risk factors for impaired fertility at HL diagnosis and after treatment.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Laddaga FE, Masciopinto P, Nardelli C, et al. In male Hodgkin lymphoma patients, impaired fertility may be improved by non-gonadotoxic therapy. Br J Haematol. 2021. PMID: 34462914. doi:10.1111/bjh.17767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。